← Leaderboards
Carola A Neumann
Immune Disease Institute, Inc.
$2,924,624
Attributed
$3,123,988
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $398.7K · FY2005–23$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,123,988 · 6
By mechanism
R01$1,499,593 · 1
R56$687,118 · 1
R41$398,728 · 1
K22$318,924 · 1
F32$147,832 · 1
R03$71,793 · 1
Top collaborators
- Francisco Jose Schopfer1 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsIn VivoFibroblastsIn VitroNuclearAntioxidantsMutationMediatingCellsApoptosisOxidationBaseMalignant Breast NeoplasmMouse ModelLipidsPreventPredispositionExhibitsFamilyAgarCysteineComplexIonizing RadiationBinding (Molecular Function)
Grant awards (15)
Synergize a novel homologous recombination inhibitor with DNA damagingagents in TNBC$398,728
R41 · FY2023 · CA · contact PI
Inhibition of DNA double strand break repair in TNBC by nitro-fatty acids$345,144
R56 · FY2020 · CA · contact PI
Inhibition of DNA double strand break repair in TNBC by nitro-fatty acids$341,974
R56 · FY2019 · CA · contact PI
The Role of Peroxiredoxin1 & Reactive Oxygen Species in Breast Tumor Initiation$299,444
R01 · FY2014 · CA · contact PI
The Role of Peroxiredoxin1 & Reactive Oxygen Species in Breast Tumor Initiation$300,324
R01 · FY2013 · CA · contact PI
Identifying underlying mechanisms of intracellular changes in response to caregiv$71,793
R03 · FY2013 · CA · contact PI
The Role of Peroxiredoxin1 & Reactive Oxygen Species in Breast Tumor Initiation$296,881
R01 · FY2012 · CA · contact PI
The Role of Peroxiredoxin1 & Reactive Oxygen Species in Breast Tumor Initiation$296,881
R01 · FY2011 · CA · contact PI
The Role of Peroxiredoxin1 & Reactive Oxygen Species in Breast Tumor Initiation$306,063
R01 · FY2010 · CA · contact PI
Role of Prdx 1 in Natural Killer Cells and Tumorigenesis$105,462
K22 · FY2007 · ES · contact PI
Role of Prdx 1 in Natural Killer Cells and Tumorigenesis$105,462
K22 · FY2006 · ES · contact PI
Role of Prdx 1 in Natural Killer Cells and Tumorigenesis$108,000
K22 · FY2005 · ES
REGULATION OF THE ABL TYROSINE KINASE INHIBITOR PAG$53,944
F32 · FY2003 · ES
REGULATION OF THE ABL TYROSINE KINASE INHIBITOR PAG$50,116
F32 · FY2002 · ES
REGULATION OF THE ABL TYROSINE KINASE INHIBITOR PAG$43,772
F32 · FY2001 · ES